Association of interleukin-6 and tumor necrosis factor-&#945; with mortality in hospitalized patients with cancer.

Stoll, Joseph R; Vaidya, Toral S; Mori, Shoko; Dusza, Stephen W; Lacouture, Mario E; Markova, Alina

Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer.

Stoll, Joseph R; Vaidya, Toral S; Mori, Shoko; Dusza, Stephen W; Lacouture, Mario E; Markova, Alina.

Afiliação

Stoll JR; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Vaidya TS; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Mori S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Dusza SW; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Lacouture ME; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Weill Cornell Medical College, New York, New York.
Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Weill Cornell Medical College, New York, New York. Electronic address: markovaa@mskcc.org.

J Am Acad Dermatol ; 84(2): 273-282, 2021 Feb.

Article em En | MEDLINE | ID: mdl-32171811

Assuntos

Antineoplásicos/efeitos adversos; Biomarcadores Tumorais/sangue; Toxidermias/diagnóstico; Interleucina-6/sangue; Neoplasias/mortalidade; Fator de Necrose Tumoral alfa/sangue; Biomarcadores Tumorais/imunologia; Toxidermias/sangue; Toxidermias/imunologia; Toxidermias/mortalidade; Feminino; Seguimentos; Mortalidade Hospitalar; Humanos; Interleucina-10/sangue; Interleucina-10/imunologia; Interleucina-6/imunologia; Estimativa de Kaplan-Meier; Masculino; Pessoa de Meia-Idade; Neoplasias/sangue; Neoplasias/tratamento farmacológico; Neoplasias/imunologia; Prognóstico; Estudos Retrospectivos; Medição de Risco/métodos; Índice de Gravidade de Doença; Fator de Necrose Tumoral alfa/imunologia

Palavras-chave

biomarker; cytokine; drug rash; drug reaction; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome; graft-versus-host disease; interleukin-6 (IL-6); mortality; severe cutaneous adverse reaction; survival; tumor necrosis factor alpha (TNF-α)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Interleucina-6 / Fator de Necrose Tumoral alfa / Toxidermias / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google